E-LIB Suche - Ergebnisse für: Appleman, L.J.

1

122P Casdozokitug (casdozo, SRF388), a first-in-class IL-27..:

Marron, T.U. ; Naing, A. ; Mantia, C....
Immuno-Oncology and Technology. 20 (2023) - p. 100594 , 2023

Link: https://doi.org/10.1016/..

2

28P 3-year follow-up analysis of disease-free survival in C..:

Stenner-Liewen, F. ; Galsky, M. ; Bajorin, D....
Immuno-Oncology and Technology. 20 (2023) - p. 100497 , 2023

Link: https://doi.org/10.1016/..

3

KEYNOTE-365 cohort D: Pembrolizumab (pembro) plus abiratero..:

Todenhöfer, T. ; Piulats, J.M. ; Ferrario, C....
European Urology. 81 (2022) - p. S789-S790 , 2022

Link: https://doi.org/10.1016/..

4

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro..:

Gravis, G. ; Kolinsky, M. ; Mourey, L....
European Urology Open Science. 19 (2020) - p. e871-e872 , 2020

Link: https://doi.org/10.1016/..

5

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro..:

Feyerabend, S. ; Berry, W. ; Fong, P....
European Urology Open Science. 19 (2020) - p. e875-e876 , 2020

Link: https://doi.org/10.1016/..

6

Radium-223 for Men with Pretreated Metastatic Castrate Resi..:

Kalash, R. ; Horne, Z.D. ; Smith, R.P....
International Journal of Radiation Oncology*Biology*Physics. 102 (2018) 3 - p. e121 , 2018

Link: https://doi.org/10.1016/..

7

Efficacy of cabozantinib vs everolimus in advanced renal ce..:

Bracarda, S. ; Choueiri, T.K. ; Powles, T....
European Journal of Cancer. 72 (2017) - p. S196 , 2017

Link: https://doi.org/10.1016/..

8

First-in-human phase I study of copanlisib (BAY 80-6946), a..:

Patnaik, A. ; Appleman, L.J. ; Tolcher, A.W....
Annals of Oncology. 27 (2016) 10 - p. 1928-1940 , 2016

Link: https://doi.org/10.1093/..

9

870 A phase 2 trial of prostate specific membrane antigen a..:

Petrylak, D. ; Smith, D.C. ; Appleman, L.J....
European Urology Supplements. 13 (2014) 1 - p. e870 , 2014

Link: https://doi.org/10.1016/..

10

90 PRECLINICAL STUDIES OF ANA598 COMBINED WITH OTHER ANTI-H..:

Thompson, P. ; Patel, R. ; Steffy, K..
Journal of Hepatology. 50 (2009) - p. S37 , 2009

Link: https://doi.org/10.1016/..

11

944 PK/PD ASSESSMENT OF A PHASE 1 HEALTHY VOLUNTEER STUDY W..:

Fletcher, S. ; Bauman, L. ; Eam, B....
Journal of Hepatology. 50 (2009) - p. S343 , 2009

Link: https://doi.org/10.1016/..

12

7109 Phase 2 results of ABT-869 treatment in patients with ..:

Tannir, N. ; Wong, Y. ; Kollmannsberger, C....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 425 , 2009

Link: https://doi.org/10.1016/..

13

1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE..:

Lawitz, E. ; Rodriguez-Torres, M. ; DeMicco, M....
Journal of Hepatology. 50 (2009) - p. S384 , 2009

Link: https://doi.org/10.1016/..

14

Phase I trial of oral MAC-321 in subjects with advanced mal..:

Lockhart, A. C. ; Bukowski, R. ; Rothenberg, M. L....
Cancer Chemotherapy and Pharmacology. 60 (2006) 2 - p. 203-209 , 2006

Link: https://doi.org/10.1007/..

15

404 POSTER Pharmacodynamics (pd) of x1880, a novel spectrum..:

LoRusso, P. ; Appleman, L. ; Zhu, A....
European Journal of Cancer Supplements. 4 (2006) 12 - p. 124 , 2006

Link: https://doi.org/10.1016/..